Solving the puzzle of follicular lymphoma.
Longo
D L
DL
National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use; D018572:Disease-Free Survival; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use; D008223:Lymphoma / Q000145:classification; D008224:Lymphoma, Follicular / Q000628:therapy*; D012074:Remission Induction; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000922:Immunotoxins; D016898:Interferon-alpha; D000069283:Rituximab